Sam Brusco, Associate Editor01.03.24
Dental artificial intelligence (AI) platform VideaHealth gained U.S. Food and Drug Administration (FDA) 510(k) clearance for Videa Dental Assist.
The tool includes over 30 AI algorithms to cover the most common dental diseases. Videa Dental Assist’s clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages three years and older, and other AI models to allow subtle detections for all ages.
The FDA nod marks the first pediatric radiology AI clearance in dentistry, according to the company.
Florian Hillen, CEO of VideaHealth, said, “This is one of the largest, most impactful FDA clearances in the history of healthcare and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients.”
The company also said thousands of clinicians have already selected VideaAI as their dental AI tool of choice, including the nation’s largest DSO, Heartland Dental.
“It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand,” said Heartland Dental’s senior VP of clinical operations Dr. Tim Quirt. “We are proud to partner with VideaHealth in this fast-moving field because their vision, mission and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint.”
The tool includes over 30 AI algorithms to cover the most common dental diseases. Videa Dental Assist’s clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages three years and older, and other AI models to allow subtle detections for all ages.
The FDA nod marks the first pediatric radiology AI clearance in dentistry, according to the company.
Florian Hillen, CEO of VideaHealth, said, “This is one of the largest, most impactful FDA clearances in the history of healthcare and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients.”
The company also said thousands of clinicians have already selected VideaAI as their dental AI tool of choice, including the nation’s largest DSO, Heartland Dental.
“It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand,” said Heartland Dental’s senior VP of clinical operations Dr. Tim Quirt. “We are proud to partner with VideaHealth in this fast-moving field because their vision, mission and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint.”